Cargando…
Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Seniors With IBD
The risk of hospitalization and death from Coronavirus disease-19 (COVID-19) increases with age. The extreme elderly have been particularly vulnerable, with those above the age of 80 having a case-fatality rate as high as 15%. Aging of the immune system can lead to impaired inflammatory responses wh...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570427/ https://www.ncbi.nlm.nih.gov/pubmed/34755037 http://dx.doi.org/10.1093/jcag/gwab025 |
_version_ | 1784594836866727936 |
---|---|
author | Bernstein, Charles N Singh, Harminder Murthy, Sanjay K Nguyen, Geoffrey C Benchimol, Eric I Bitton, Alain Kuenzig, M Ellen Huang, James Guoxian Jones, Jennifer L Lee, Kate Targownik, Laura E Windsor, Joseph W Mukhtar, Mariam S Tandon, Parul Kaplan, Gilaad G |
author_facet | Bernstein, Charles N Singh, Harminder Murthy, Sanjay K Nguyen, Geoffrey C Benchimol, Eric I Bitton, Alain Kuenzig, M Ellen Huang, James Guoxian Jones, Jennifer L Lee, Kate Targownik, Laura E Windsor, Joseph W Mukhtar, Mariam S Tandon, Parul Kaplan, Gilaad G |
author_sort | Bernstein, Charles N |
collection | PubMed |
description | The risk of hospitalization and death from Coronavirus disease-19 (COVID-19) increases with age. The extreme elderly have been particularly vulnerable, with those above the age of 80 having a case-fatality rate as high as 15%. Aging of the immune system can lead to impaired inflammatory responses where eradication of an organism such as Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV2) is inadequate but is exaggerated in such a way as to enhance pneumonia and acute respiratory distress syndrome. Frailty and comorbidity are both more common in the elderly, and these can enhance the morbidity and mortality from COVID-19. Studies from Northern California and Italy suggest that elderly persons with inflammatory bowel disease (IBD) were more likely to acquire SARS-CoV-2 infection than youths with IBD. While the specific impact of age-related comorbidity is less well established among people with IBD who acquire COVID-19, data from the Surveillance Epidemiology of Coronavirus Under Research Exclusion (SECURE-IBD) database reported that having two or more chronic illnesses was independently associated with developing severe COVID-19 among people with IBD. Despite having exaggerated auto-inflammatory responses, people with IBD do not appear to have an overall increased risk of developing severe COVID-19 than the general population. However, whether seniors with IBD do worse once they acquire COVID-19 compared with seniors without IBD is not known. The advent of telehealth care has posed an information technology challenge for many seniors with and without IBD. Most persons with IBD have expressed satisfaction with virtual IBD health care (phone or video-based visits). While the elderly may have less robust immune responses to vaccinations, learning from experiences with other vaccination programs, especially influenza, have shown that vaccinating seniors decreases both morbidity and mortality and, in turn, healthcare resources. |
format | Online Article Text |
id | pubmed-8570427 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-85704272021-11-08 Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Seniors With IBD Bernstein, Charles N Singh, Harminder Murthy, Sanjay K Nguyen, Geoffrey C Benchimol, Eric I Bitton, Alain Kuenzig, M Ellen Huang, James Guoxian Jones, Jennifer L Lee, Kate Targownik, Laura E Windsor, Joseph W Mukhtar, Mariam S Tandon, Parul Kaplan, Gilaad G J Can Assoc Gastroenterol Supplement Articles The risk of hospitalization and death from Coronavirus disease-19 (COVID-19) increases with age. The extreme elderly have been particularly vulnerable, with those above the age of 80 having a case-fatality rate as high as 15%. Aging of the immune system can lead to impaired inflammatory responses where eradication of an organism such as Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV2) is inadequate but is exaggerated in such a way as to enhance pneumonia and acute respiratory distress syndrome. Frailty and comorbidity are both more common in the elderly, and these can enhance the morbidity and mortality from COVID-19. Studies from Northern California and Italy suggest that elderly persons with inflammatory bowel disease (IBD) were more likely to acquire SARS-CoV-2 infection than youths with IBD. While the specific impact of age-related comorbidity is less well established among people with IBD who acquire COVID-19, data from the Surveillance Epidemiology of Coronavirus Under Research Exclusion (SECURE-IBD) database reported that having two or more chronic illnesses was independently associated with developing severe COVID-19 among people with IBD. Despite having exaggerated auto-inflammatory responses, people with IBD do not appear to have an overall increased risk of developing severe COVID-19 than the general population. However, whether seniors with IBD do worse once they acquire COVID-19 compared with seniors without IBD is not known. The advent of telehealth care has posed an information technology challenge for many seniors with and without IBD. Most persons with IBD have expressed satisfaction with virtual IBD health care (phone or video-based visits). While the elderly may have less robust immune responses to vaccinations, learning from experiences with other vaccination programs, especially influenza, have shown that vaccinating seniors decreases both morbidity and mortality and, in turn, healthcare resources. Oxford University Press 2021-11-05 /pmc/articles/PMC8570427/ /pubmed/34755037 http://dx.doi.org/10.1093/jcag/gwab025 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of the Canadian Association of Gastroenterology. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Supplement Articles Bernstein, Charles N Singh, Harminder Murthy, Sanjay K Nguyen, Geoffrey C Benchimol, Eric I Bitton, Alain Kuenzig, M Ellen Huang, James Guoxian Jones, Jennifer L Lee, Kate Targownik, Laura E Windsor, Joseph W Mukhtar, Mariam S Tandon, Parul Kaplan, Gilaad G Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Seniors With IBD |
title | Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Seniors With IBD |
title_full | Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Seniors With IBD |
title_fullStr | Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Seniors With IBD |
title_full_unstemmed | Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Seniors With IBD |
title_short | Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Seniors With IBD |
title_sort | crohn’s and colitis canada’s 2021 impact of covid-19 and inflammatory bowel disease in canada: seniors with ibd |
topic | Supplement Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570427/ https://www.ncbi.nlm.nih.gov/pubmed/34755037 http://dx.doi.org/10.1093/jcag/gwab025 |
work_keys_str_mv | AT bernsteincharlesn crohnsandcolitiscanadas2021impactofcovid19andinflammatoryboweldiseaseincanadaseniorswithibd AT singhharminder crohnsandcolitiscanadas2021impactofcovid19andinflammatoryboweldiseaseincanadaseniorswithibd AT murthysanjayk crohnsandcolitiscanadas2021impactofcovid19andinflammatoryboweldiseaseincanadaseniorswithibd AT nguyengeoffreyc crohnsandcolitiscanadas2021impactofcovid19andinflammatoryboweldiseaseincanadaseniorswithibd AT benchimolerici crohnsandcolitiscanadas2021impactofcovid19andinflammatoryboweldiseaseincanadaseniorswithibd AT bittonalain crohnsandcolitiscanadas2021impactofcovid19andinflammatoryboweldiseaseincanadaseniorswithibd AT kuenzigmellen crohnsandcolitiscanadas2021impactofcovid19andinflammatoryboweldiseaseincanadaseniorswithibd AT huangjamesguoxian crohnsandcolitiscanadas2021impactofcovid19andinflammatoryboweldiseaseincanadaseniorswithibd AT jonesjenniferl crohnsandcolitiscanadas2021impactofcovid19andinflammatoryboweldiseaseincanadaseniorswithibd AT leekate crohnsandcolitiscanadas2021impactofcovid19andinflammatoryboweldiseaseincanadaseniorswithibd AT targowniklaurae crohnsandcolitiscanadas2021impactofcovid19andinflammatoryboweldiseaseincanadaseniorswithibd AT windsorjosephw crohnsandcolitiscanadas2021impactofcovid19andinflammatoryboweldiseaseincanadaseniorswithibd AT mukhtarmariams crohnsandcolitiscanadas2021impactofcovid19andinflammatoryboweldiseaseincanadaseniorswithibd AT tandonparul crohnsandcolitiscanadas2021impactofcovid19andinflammatoryboweldiseaseincanadaseniorswithibd AT kaplangilaadg crohnsandcolitiscanadas2021impactofcovid19andinflammatoryboweldiseaseincanadaseniorswithibd |